Abstract: Defined peptide subunits of Streptococcus mutans antigen I/II (SAI/II) are useful as agents to prevent and treat dental caries either by eliciting an immunological response or by preventing adhesion of S. mutans to the tooth.
Type:
Grant
Filed:
December 9, 1999
Date of Patent:
December 31, 2002
Assignee:
The Council of Governors of the United Medical & Dental
School of Guy's and St. Thomas's Hospitals
Abstract: Defined peptide subunits of Streptococcus mutans antigen I/II are useful as agents to prevent and treat dental caries either by eliciting an immunological response or by preventing adhesion of S. mutans to the tooth.
Type:
Grant
Filed:
October 20, 1997
Date of Patent:
February 15, 2000
Assignee:
The Council of Governors of the United Medical & Dental School of Guy's & St. Thomas's Hospitals
Abstract: Monoclonal antibodies which bind the surface antigen I/II of Streptococcus sobrinus serotype d and cross react with the surface antigen I/II of Streptococcus mutans serotypes c, e, f and g and method for producing the antibody. Compositions comprising the antibody used in a method to combat dental caries in a mammal.
Type:
Grant
Filed:
September 7, 1994
Date of Patent:
May 21, 1996
Assignee:
Council of Governors of the United Medical and Dental Schools of Guy's and St. Thomas Hospital
Abstract: A method of combatting dental caries in a mammal comprises topical application to a surface of a tooth in the mammals mouth of a monoclonal antibody raised against antigen I or antigen I/II of Streptococcus mutans serotype c.
Type:
Grant
Filed:
November 30, 1992
Date of Patent:
October 4, 1994
Assignee:
Council of Governors of the United Medical and Dental Schools of Guy's and St. Thomas's Hospitals
Abstract: An antigenic material having a molecular weight of 3800-4500, and useful in the preparation of an anticaries vaccine is produced from a known antigenic material, antigen I/II of molecular weight 185,000 daltons obtained from the culture supernatant of Streptococcus mutans. The smaller molecular weight fraction of the invention contains the same antigenic determinants as the known 185,000 dalton material but the lower molecular weight material can be used with less side effects. The antigenic material can be used for the production of vaccine preparations that could be administered parenterally or by topical application to the gums.
Type:
Grant
Filed:
February 10, 1984
Date of Patent:
June 10, 1986
Assignee:
Council of Governors of the United Medical and Dental Schools of Guy's and St. Thomas's Hospitals